Publications BPE group

Göbel, S.; Pelz, L.; Silva, C. A. T.; Brühlmann, B.; Hill, C.; Altomonte, J.; Kamen, A.; Reichl, U.; Genzel, Y.: Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology 108 (1), 240 (2024)

Heyer, R.; Hellwig, P.; Maus, I.; Walke, D.; Schlüter, A.; Hassa, J.; Sczyrba, A.; Tubbesing, T.; Klocke, M.; Mächtig, T. et al.; Schallert, K.; Seick, I.; Reichl, U.; Benndorf, D.: Breakdown of hardly degradable carbohydrates (lignocellulose) in a two-stage anaerobic digestion plant is favored in the main fermenter. Water Research 250, 121020 (2024)

Huber, N.; Alcalá Orozco, E. A.; Rexer, T.; Reichl, U.; Klamt, S.: Model-based optimization of cell-free enzyme cascades exemplified for the production of GDP-fucose. Metabolic Engineering 81, pp. 10 - 25 (2024)

Pelz, L.; Dogra, T.; Marichal-Gallardo, P.; Hein, M. D.; Hemissi, G.; Kupke, S. Y.; Genzel, Y.; Reichl, U.: Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology 108, 97 (2024)

Riedel, R.; Commichau, F. M.; Benndorf, D.; Hertel, R.; Holzer, K.; Hoelzle, L. E.; Mardoukhi, M. S. Y.; Noack, L. E.; Martienssen, M.: Biodegradation of selected aminophosphonates by the bacterial isolate Ochrobactrum sp. BTU1. Microbiological Research 280, 127600 (2024)

Rüdiger, D.; Piasecka, J.; Küchler, J.; Pontes, C.; Laske, T.; Kupke, S. Y.; Reichl, U.: Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 27 (4), 109421 (2024)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Thiele, K.; Reichl, U.; Genzel, Y.: From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 24 (4), 2300245 (2024)

Pelz, L.; Rüdiger, D.; Hein, M.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Engineered defective interfering particles of influenza A virus for antiviral treatment. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Pelz, L.; Dogra, T.; Rüdiger, D.; Boehme, J.; Kershaw, O.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Defective Interfering Particles of Influenza A Virus As Broad-Spectrum Antivirals. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Piasecka, J.; Rüdiger, D.; Küchler, J.; Kupke, S. Y.; Reichl, U.: Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Hellwig, P.; Dittrich, A.; Heyer, R.; Reichl, U.; Benndorf, D.: Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistry. (2024)

Karsten, C. B.; Buettner, F. F. R.; Cajic, S.; Nehlmeier, I.; Roshani, B.; Klippert, A.; Sauermann, U.; Stolte-Leeb, N.; Reichl, U.; Gerardy-Schahn, R. et al.; Rapp, E.; Stahl-Hennig, C.; Pöhlmann, S.: Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. (2024)